PARK7 and synucleinopathy: Furthermore, integrating αSyn measurements with additional neurodegenerative biomarkers—such as DJ-1 for oxidative stress or inflammatory cytokines—may improve diagnostic specificity and facilitate differentiation between PD and other synucleinopathies.